CALTON & ASSOCIATES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$113,848
-3.0%
22,907
-3.6%
0.05%
-1.9%
Q1 2023$117,382
+14.4%
23,761
+45.6%
0.05%
+35.0%
Q4 2022$102,616
-16.6%
16,314
+42.3%
0.04%
-42.9%
Q3 2022$123,000
-37.6%
11,468
-33.9%
0.07%
-35.8%
Q2 2022$197,000
+18.7%
17,352
-5.3%
0.11%
+122.4%
Q1 2022$166,000
-32.2%
18,329
+92.0%
0.05%
-9.3%
Q3 2021$245,000
+14.5%
9,546
+57.3%
0.05%
+28.6%
Q1 2021$214,0006,0670.04%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders